flag_-_union_flag

New web portal highlights UK strengths in medicines manufacturing

December 1, 2015
Manufacturing and Production ABPI, KTN, Knowledge Transfer Network, Medicines Manufacturing Industry Partnership, UK, manufacturing, mmip, production

A new web portal has been launched to provide a platform to promote the UK’s strengths and capabilities in medicines …

Medicines Patent Pool

Collaboration between MPP and University of Liverpool targets HIV nanomedicines

December 1, 2015
Manufacturing and Production, Research and Development AIDS, HIV, Medicines Patent Pool, antiretrovirals, nanomedicines

The Medicines Patent Pool (MPP) and the University of Liverpool have agreed a partnership to use the university’s solid drug …

Gilead image

EU approval for Gilead’s HIV combo Genvoya

December 1, 2015
Manufacturing and Production, Sales and Marketing European Commission, Genvoya, Gilead, Gilead Sciences, HIV, TDF, World Aids Day, european union, taf

Gilead Sciences has won marketing authorisation from the European Commission (EC) for the once-daily single tablet regimen Genvoya as an …

Empliciti logo

FDA approves BMS and AbbVie’s Empliciti for multiple myeloma

December 1, 2015
Manufacturing and Production, Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, Empliciti, FDA, elotuzumab, multiple myeloma

The US healthcare regulator has approved Empliciti – a multiple myeloma treatment co-developed by Bristol-Myers Squibb and AbbVie. The FDA …

Laying bare the complexities of the pricing issue

November 30, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, access, affordability, cost of medicines

Richard Bergström, director general of the European Federation of Pharmaceutical Industry and Associations (EFPIA), on why full transparency in cost discussions …

Clinigen logo

Clinigen launches UK managed access program for Takeda’s ixazomib

November 30, 2015
Sales and Marketing Clinigen, Takeda, ixazomib, managed access, multiple myeloma, oncology

Clinigen and Takeda have struck a deal to allow patients in the UK to access the multiple myeloma drug ixazomib …

robert_k

Ablynx appoints Robert Zeldin as new chief medical officer

November 30, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Ablynx, Robert Zeldin

Ablynx has appointed Dr Robert Zeldin as chief medical officer (CMO) effective from 1 December 2015.  Dr Zeldin will lead …

Almirall logo

Almirall to acquire Poli Group’s skin drugs

November 30, 2015
Sales and Marketing Almirall, Poldi, dermatology, skin, specialty pharma

Almirall has agreed to acquire 100% of the share capital of Poli Group Holding as the Spanish pharma company continues …

anastrazole

Pharma company vows to plough profits back into R&D

November 30, 2015
Sales and Marketing Australia, R&D, breast cancer, profits, sales, social enterprise

An Australian pharma company has adopted a social enterprise model in order to be able to donate 100% of its …

ASH 2014 meeting

Bayer and Novartis to debut new data at ASH 2015

November 30, 2015
Research and Development, Sales and Marketing American Society of Hematology, Bayer, Conference, Novartis, ash, clinical trials, haematology, oncology

Pharma firms will present clinical trial results for the pipeline drugs they are pinning their 2016 hopes for success on, …

SHL Creates Buzz at the 2015 PDA

November 30, 2015
Medical Communications auto injectors, connectivity, pda, pen injectors, pre-filled drug delivery

With a newly designed booth to reflect SHL’s Scandinavian roots, SHL not only brought to this year’s PDA a booth …

computer_industry_entrepreneur_workshop

Promoting diversity in the pharma industry: 10 female pharma rising stars

November 27, 2015
Medical Communications, Sales and Marketing Jobs, Women in pharma, careers, diversity, pharmajobs, recruitment

While some parts of the pharma industry can be dominated by men there are plenty of women making waves in …

Biogen image

Sobi and Biogen’s haemophilia A treatment EU-approved

November 27, 2015
Sales and Marketing Biogen, elocta, haemophilia a, sobi

Elocta, the haemophilia A treatment developed by the Swedish Orphan Biovitrum (Sobi) and Biogen, has received European Commission approval as …

willy_simon

Willy Simon joins Tiziana as non-executive director

November 27, 2015
Research and Development Tiziana life sciences

Tiziana Life Sciences has appointed Willy Simon as a non-executive director who brings the benefit of a long and successful …

Sun Pharma logo

Pharma companies look to boost employee retention

November 27, 2015
Medical Communications HR, India, Jobs, recruitment

Drug firms in India are devising novel ‘benching’ models to manage employee turnover. Attrition rates for pharma companies in India …

Mylan image

Mylan launches digital adherence programme for heart patients

November 27, 2015
Medical Communications Canada, Mavik, Mylan, pharmacies, trandolapril

Mylan has launched an innovative digital medication adherence and engagement program for patients with high blood pressure. The digital programme, called …

michael_linden_300dpi

Pfizer hires new lead for gene therapy research centre

November 26, 2015
Medical Communications, Research and Development Pfizer

Pfizer has hired Professor Michael Linden to lead its new gene therapy research centre in London.  Professor Michael Linden has …

praxbind

Boehringer’s Praxbind reversal agent wins EU approval

November 26, 2015
Medical Communications, Research and Development, Sales and Marketing

The European Commission has approved Boehringer Ingelheim’s Praxbind (idarucizumab)- a treatment to rapidly and specifically reverse the anticoagulant effects of …

abpi_code_of_practice_2011

Bayer takes on Actavis in ABPI code conduct breach

November 26, 2015
Medical Communications, Sales and Marketing ABPI, Actavis, Bayer, PMCPA

The Prescription Medicines Code of Practice Authority (PMCPA) has ruled in favour of Bayer in a case brought against Actavis. …

gsk_manufactures_daraprim_for_the_uk_market

Shkreli Daraprim price U-turn prompts renewed fury

November 26, 2015
Medical Communications, Research and Development, Sales and Marketing

Turing CEO Martin Shkreli has sparked yet more criticism, after going back on a pledge to cut the price of …

The Gateway to Local Adoption Series

Latest content